PL3390412T3 - Rozpuszczalne w wodzie pochodne związków 3,5-difenylodiazolowych - Google Patents
Rozpuszczalne w wodzie pochodne związków 3,5-difenylodiazolowychInfo
- Publication number
- PL3390412T3 PL3390412T3 PL16809425T PL16809425T PL3390412T3 PL 3390412 T3 PL3390412 T3 PL 3390412T3 PL 16809425 T PL16809425 T PL 16809425T PL 16809425 T PL16809425 T PL 16809425T PL 3390412 T3 PL3390412 T3 PL 3390412T3
- Authority
- PL
- Poland
- Prior art keywords
- diphenyl
- water
- soluble derivatives
- diazole compounds
- diazole
- Prior art date
Links
- JXHKUYQCEJILEI-UHFFFAOYSA-N 3,5-diphenyl-1h-pyrazole Chemical class C=1C(C=2C=CC=CC=2)=NNC=1C1=CC=CC=C1 JXHKUYQCEJILEI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199972 | 2015-12-14 | ||
| PCT/EP2016/081084 WO2017102893A1 (en) | 2015-12-14 | 2016-12-14 | Water-soluble derivatives of 3,5-diphenyl-diazole compounds |
| EP16809425.8A EP3390412B1 (en) | 2015-12-14 | 2016-12-14 | Water-soluble derivatives of 3,5-diphenyl-diazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3390412T3 true PL3390412T3 (pl) | 2021-10-25 |
Family
ID=54850017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16809425T PL3390412T3 (pl) | 2015-12-14 | 2016-12-14 | Rozpuszczalne w wodzie pochodne związków 3,5-difenylodiazolowych |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10308671B2 (pl) |
| EP (1) | EP3390412B1 (pl) |
| JP (1) | JP6898931B2 (pl) |
| CN (1) | CN108473516B (pl) |
| AU (1) | AU2016372408B2 (pl) |
| BR (1) | BR112018011994B1 (pl) |
| CA (1) | CA3008334C (pl) |
| CL (1) | CL2018001570A1 (pl) |
| DK (1) | DK3390412T3 (pl) |
| ES (1) | ES2873510T3 (pl) |
| HU (1) | HUE054815T2 (pl) |
| IL (1) | IL260011B (pl) |
| MX (1) | MX2018006877A (pl) |
| NZ (1) | NZ742979A (pl) |
| PH (1) | PH12018501276A1 (pl) |
| PL (1) | PL3390412T3 (pl) |
| PT (1) | PT3390412T (pl) |
| RU (1) | RU2764131C2 (pl) |
| WO (1) | WO2017102893A1 (pl) |
| ZA (1) | ZA201803865B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH713150A2 (fr) * | 2016-11-23 | 2018-05-31 | Eta Sa Mft Horlogere Suisse | Mécanisme régulateur à résonateur rotatif à guidage flexible entretenu par un échappement libre à ancre. |
| US10368502B2 (en) | 2017-09-25 | 2019-08-06 | Multiple Energy Technologies Llc | Bioceramic and carbon-based hydroponic systems, methods and devices |
| AU2020386151B2 (en) | 2019-11-19 | 2023-09-21 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel compounds for the diagnosis, treatment and prevention of diseases associated with the aggregation of alpha-synuclein |
| WO2023166045A1 (en) * | 2022-03-01 | 2023-09-07 | Modag Gmbh | Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use |
| CN115337301A (zh) * | 2022-07-22 | 2022-11-15 | 汕头大学医学院第一附属医院 | Anle138b在制备改善饮食诱导胰岛素抵抗药物中的应用 |
| CN116399983B (zh) * | 2023-06-09 | 2023-08-15 | 天津辰欣药物研究有限公司 | 一种利用gc-ms法检测二叔丁基氯甲基磷酸酯残留量的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| KR20080016645A (ko) * | 2005-06-16 | 2008-02-21 | 씨브이 쎄러퓨틱스, 인코포레이티드 | Ａ２ｂ 아데노신 수용체 길항제의 프로드러그 |
| US8415479B2 (en) * | 2008-03-31 | 2013-04-09 | Renascience Co., Ltd. | Inhibitor of plasminogen activator inhibitor-1 |
| PT2307381T (pt) * | 2008-06-09 | 2021-03-15 | Univ Muenchen Ludwig Maximilians | Novas drogas para inibir a agregação de proteínas envolvidas em doenças relacionadas com a agregação de proteínas e/ou doenças neurodegenerativas |
| EP2585455B1 (en) * | 2010-06-24 | 2019-08-07 | The Regents of the University of California | Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
| PT2864292T (pt) * | 2012-06-08 | 2017-07-10 | Theravance Biopharma R&D Ip Llc | Inibidores de neprisilina |
-
2016
- 2016-12-14 PT PT168094258T patent/PT3390412T/pt unknown
- 2016-12-14 RU RU2018125590A patent/RU2764131C2/ru active
- 2016-12-14 MX MX2018006877A patent/MX2018006877A/es unknown
- 2016-12-14 CA CA3008334A patent/CA3008334C/en active Active
- 2016-12-14 AU AU2016372408A patent/AU2016372408B2/en active Active
- 2016-12-14 US US16/062,258 patent/US10308671B2/en active Active
- 2016-12-14 EP EP16809425.8A patent/EP3390412B1/en active Active
- 2016-12-14 HU HUE16809425A patent/HUE054815T2/hu unknown
- 2016-12-14 BR BR112018011994-6A patent/BR112018011994B1/pt active IP Right Grant
- 2016-12-14 PL PL16809425T patent/PL3390412T3/pl unknown
- 2016-12-14 NZ NZ742979A patent/NZ742979A/en unknown
- 2016-12-14 JP JP2018532323A patent/JP6898931B2/ja active Active
- 2016-12-14 DK DK16809425.8T patent/DK3390412T3/da active
- 2016-12-14 WO PCT/EP2016/081084 patent/WO2017102893A1/en active Application Filing
- 2016-12-14 CN CN201680073089.1A patent/CN108473516B/zh active Active
- 2016-12-14 ES ES16809425T patent/ES2873510T3/es active Active
-
2018
- 2018-06-11 ZA ZA2018/03865A patent/ZA201803865B/en unknown
- 2018-06-13 CL CL2018001570A patent/CL2018001570A1/es unknown
- 2018-06-13 IL IL260011A patent/IL260011B/en unknown
- 2018-06-14 PH PH12018501276A patent/PH12018501276A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE054815T2 (hu) | 2021-10-28 |
| ZA201803865B (en) | 2019-04-24 |
| MX2018006877A (es) | 2018-09-18 |
| CA3008334C (en) | 2024-01-02 |
| AU2016372408A1 (en) | 2018-06-21 |
| CA3008334A1 (en) | 2017-06-22 |
| CN108473516B (zh) | 2021-06-18 |
| PT3390412T (pt) | 2021-06-22 |
| NZ742979A (en) | 2022-05-27 |
| PH12018501276A1 (en) | 2019-01-28 |
| US10308671B2 (en) | 2019-06-04 |
| JP6898931B2 (ja) | 2021-07-07 |
| RU2018125590A3 (pl) | 2020-04-21 |
| EP3390412A1 (en) | 2018-10-24 |
| US20180370997A1 (en) | 2018-12-27 |
| IL260011B (en) | 2021-12-01 |
| WO2017102893A1 (en) | 2017-06-22 |
| CL2018001570A1 (es) | 2018-12-28 |
| IL260011A (en) | 2018-07-31 |
| DK3390412T3 (da) | 2021-06-21 |
| RU2018125590A (ru) | 2020-01-20 |
| BR112018011994B1 (pt) | 2022-07-19 |
| KR20180089511A (ko) | 2018-08-08 |
| JP2019501167A (ja) | 2019-01-17 |
| BR112018011994A2 (pt) | 2018-12-04 |
| ES2873510T3 (es) | 2021-11-03 |
| AU2016372408B2 (en) | 2021-05-13 |
| CN108473516A (zh) | 2018-08-31 |
| RU2764131C2 (ru) | 2022-01-13 |
| EP3390412B1 (en) | 2021-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264092A (en) | 1, 3-dihydroxy-phenyl derivatives are useful as immunomodulators | |
| HK1255045A1 (zh) | 取代的氧代吡啶衍生物 | |
| IL254870A0 (en) | Quinoxaline histories are transmuted | |
| IL253381A0 (en) | History of h9-pyrrolo-dipyridine | |
| IL271607A (en) | New azaquinoline histories | |
| HRP20200133T1 (hr) | Novi supstituirani derivati cijanoindolina kao inhibitori nik | |
| IL260011B (en) | History of water-soluble 5,3-diphenyldiazole compounds | |
| HK1245258A1 (zh) | 新的二氟酮酰胺衍生物 | |
| HUE058182T2 (hu) | Grizeofulvin vegyület | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| SG11201803584RA (en) | 1,4-dicarbonyl-piperidyl derivatives | |
| HK1256825A1 (zh) | 取代的5，6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
| HK1254800A1 (zh) | 2，3，4，5-四氫吡啶-6-胺衍生物 | |
| HK1252767A1 (zh) | 作為eaat3抑制劑的吡唑-吡啶衍生物 | |
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| IL247868B (en) | Phenylpiperidinecarboxamide derivatives as fungicides | |
| PT3319956T (pt) | Derivados de oxopiridina substituída | |
| TWI562978B (en) | Method for preparation of 1,4-cyclohexanedialkanol | |
| HUP1500451A2 (en) | Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates |